Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’

Abstract

(2023), EACS Abstracts. HIV Med, 24: 3–675. https://doi.org/10.1111/hiv.13572

(2023), Late breaker abstracts. HIV Med, 24: 676–708. https://doi.org/10.1111/hiv.13573

(2023), Clinical Case Abstracts. HIV Med, 24: 709–788. https://doi.org/10.1111/hiv.13574

The EACS abstracts listed below were inadvertently included, but were initially rejected from the programme by the scientific committee. These have been withdrawn and removed from online publication.

We apologize for these errors.

p.6, EACS2023: 47 | Association between depression and consistency of condom use among female sex workers in Blantyre: The case of a commercial city of Malawi.

p.6, EACS2023: 59 | Formation of public health policy on HIV treatment issues: Asian perspectives.

p.7, EACS2023: 81 | Prevalence and impact of mental health disorders on people living with HIV/AIDS in Nigeria: A systematic review.

p.7, EACS2023: 120 | Demand for HIV prevention, treatment and care services in a developing country like India.

p.8, EACS2023: 129 | Assessing the landscape and implementation of HIV-relevant policies on uptake of prevention and testing services among key populations in the WHO European Region.

p. 13, EACS2023: 256 | Pregnancy in women living with HIV in Latin America: A multi-centre crosssectional analysis across seven countries.

p.14, EACS2023: 277 | Patients' and healthcare providers' views on screening for cognitive impairment in people living with HIV: A qualitative study.

p.20, EACS2023: 533 | A survey report on the acceptance of vaginal delivery among HIV-infected pregnant women in Japan (especially about the impact of the role of midwives).

p.21, EACS2023: 562 | Cost dynamics of ARV therapy in resource limited southern countries: What needs to be done.

p.40, EACS2023: 770 | How can your pharmacist save you?

p.46–7, EACS2023: 882 | A friendly, rapid testing and counselling approach to improve linkage to care: Our experience at Latina Checkpoint and hospital Center.

p.49, EACS2023: 952 | The role of belief and knowledge in overcoming vaccination hesitancy. An HPV vaccination campaign using a ‘point of care’ friendly model.

p.53, EACS2023: 177 | Antiretroviral treatment failure for adolescents living with HIV in East African Community: A review of literature.

p.53, EACS2023: 994 | Unlocking adherence and sexual reproductive health for adolescents living with HIV in Kenya.

p.59, EACS2023: 570 | Impact of loneliness on frailty among people with HIV aged above 45 years in Taiwan.

p. 70, EACS2023: 53 | Assessing the adherence of antiretroviral therapy among pregnant women.

p.73–5, EACS2023: 170 | Adherence to antiretroviral therapy and associated factors among HIV positive adults attending care and treatment in HIV clinic at Al-Jomhoria hospital—Benghazi/Libya.

p.76–7, EACS2023: 215 | Didanosine, fatty liver and Lipodystrophy.

p.81, EACS2023: 257 | Effect of HAAST on fungal dermatosis among HIV patients in Benin City, Edo State, South–South, Nigeria.

p.87, EACS2023: 309 | Real-world experience treatment of dolutegravir plus lamivudine in antiretroviral experienced adults in Yunnan, China.

p. 94–95, EACS2023: 346 | Dolutegravir efficacy in achieving HIV viral load suppression after shifting from non-nucleoside reverse transcriptase inhibitor based regimens: An Egyptian crosssectional study.

p.139–40, EACS2023: 658 | Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) as switch strategy in virologically suppressed: Real world data from monocentric cohort.

p.145, EACS2023: 728 | Experience with the use of prolonged-release injectable CAB/RPV in outpatients.

p.148, EACS2023: 766 | Switching to dolutegravir/lamivudine in real life: Three years results from a small HIV clinic cohort.

p.156, EACS2023: 815 | Comparison and analysis of dyslipidemia rates among HIV-infected patients receiving long-term free antiretroviral therapy: A retrospective cohort study.

p. 162–3, EACS2023: 883 | Long-term durability of rilpivirine-based regimens in a large cohort.

p.173, EACS2023: 933 | The value of assessing the primary level of CD4+ T cell and viral load of HIV RNA for modelling adverse risks during ART in persons living with HIV.

p.182–3, EACS2023: 984 | Changing of renal function in PLWH switched to dual therapy regimen based on DTG in 48 weeks of follow-up.

p. 220, EACS2023: 340 | Impact of peer education on sexual health knowledge among adolescents and young persons in the Douala IV district Cameroon: Through VCT Campaigns.

p. 221, EACS2023: 371 | Choices@AZC: Prevention services in asylum seekers centers.

p.223, EACS2023: 8 | The impact of the COVID-19 pandemic on HIV infection risk, prevention and testing among persons who inject drugs (PWID) in Rajshahi city of Bangladesh.

p.226–7, EACS2023: 305 | Intervention to implement continuum of care monitoring of people living with HIV/AIDS in public health services in S˜ao Paulo, Brazil.

p.231, EACS2023: 564 | Collaboration of HIV researchers with other stake holders: Efforts to develop constructive programs of PLHIV-care.

p.234, EACS2023: 874 | ‘Don't turn that patient away, they must be seen’. A qualitative exploration of the views of London HIV clinical service providers on HIV care engagement challenges (The SHIELD Study).

p.235, EACS2023: 896 | A pre-post experimental study to assess the usefulness and feasibility of collecting routinely patient-reported outcomes in clinical practice (PROCARE).

p.238, EACS2023: 43 | Peer driven mobilization and experiential sharing improves access and acceptability to cervical cancer screening and management: A case of Childrens Aids Fund (CAFU) Jinja-Uganda.

p.239, EACS2023: 49 | Electrocardiography and screening echocardiogram in young adults perinatally and non-perinatally acquired HIV.

p.239, EACS2023: 73 | Mucocutaneous manifestations in Malagasy people living with HIV infection: A crosssectional study.

p.240, EACS2023: 109 | Common comorbidities diagnosed in the laboratory among paediatric HIV infected persons in Nigeria.

p.255, EACS2023: 481 | Weight gain and health-related quality of life in people with HIV on antiretroviral therapy.

p.256, EACS2023: 515 | Impact on weight loss of doravirine switch from integrase inhibitors in HIV patients.

p.263–4, EACS2023: 630 | Effect of starting different antiretroviral therapy drug classes on weight gain in a cohort of treatment-naïve people living with HIV in Lebanon: A retrospective cohort study.

p.286, EACS2023: 964 | Reasons for hospital admission to an infectious diseases clinic in people living with HIV.

p.292, EACS2023: 91 | The clinical impact, diagnostic performance of the WHO COVID-19 case definition and quality of life consequences of COVID-19 in people with HIV from Ukraine in 2020–2021.

p.317, EACS2023: 97 | Results among HIV-positive expectant women hospitalized with COVID-19 at Moi Teaching and Referral Hospital, Eldoret, Kenya.

p.318, EACS2023: 154 | A comparative analysis between suspected and confirmed monkeypox virus (mpox) infected patients.

p.321–2, EACS2023: 185 | Attitude towards COVID-19 vaccination among people living with HIV in Ukraine: Cross-sectional one-center study.

p.325–6, EACS2023: 486 | Prevalence and determinants for mpox vaccination among men who have sex with men.

p.328, EACS2023: 695 | Latent tuberculosis in patients with recently diagnosed HIV infection.

p.330, EACS2023: 708 | Deflazacort as a new option for diabetic patients with COVID-19.

p.333, EACS2023: 804 | Pidotimod: A therapeutic option in COVID19 outpatients.

p.339, EACS2023: 826 | Geno2pheno: Recombination detection for HIV and HEV subtypes.

p 342, EACS2023: 355 | Role of killer cell immunoglobulin-like receptors in the functional modulation of NK cell response to HIV-1 viral reservoirs in individuals on antiretroviral therapy.

p. 348, EACS2023: 5 | The problem of resistance to antiretroviral drugs in the treatment of HIV.

p. 350, EACS2023: 62 | Tackling of ARV resistance issues in resource poor nations: Overcoming hurdles infection.

p. 374, EACS2023: 860 | Online independent medical education significantly improves HIV and infectious disease physician knowledge regarding recovery of immune responses in heavily treatment-experienced people living with HIV.

p. 395, EACS2023: 214 | The significance of STI prevention education for adult's sexual health in Poland.

p. 395, EACS2023: 250 | Follow up analysis after health intervention in people living with HIV in six EU countries with focus on current state of physical activity, motivation, and sedentary behaviour: Quantitative method research approach.

p. 397, EACS2023: 463 | HIV-nutritionist physician: A new role in an HIV outpatient clinic.

p.402–3, EACS2023: 102 | The effect of refloxology therapy on immunological parameters of people living with HIV: A pilot single-center trial.

p.427, EACS2023: 110 | The effectiveness of condom use in reducing HIV transmission among homosexual populations in Nigeria: An in-depth analysis.

p.429, EACS2023: 485 | Willingness to join a clinical trial on using 4-component meningococcal serogroup B vaccine for gonorrhoea prevention in the men who have sex with men community.

p.432, EACS2023: 518 | Legal and policy barriers to migrants' access to HIV services in Armenia.

p.435–6, EACS2023: 85 | Human pappiloma virus vaccine and cancer prevention in HIV children.

p.438, EACS2023: 510 | Prevalence of advanced HIV disease at enrolment in care and associated factors during the treat all era at selected health centres in Kampala, Uganda.

p.442–3, EACS2023: 710 | Haematologic anomalies in newly diagnosed cases: A retrospective analysis from a single centre in South-East Romania.

p. 462–3, EACS2023: 282 | Co-infection of HIV and HCV among people with substance use disorders in a drug abuser treatment center in Northern Taiwan.

p.464, EACS2023: 368 | HIV-positive patients with cardiac tamponade at a tertiary care centre: A realworld experience.

p.464, EACS2023: 749 | Eliminating Hepatitis C in HIV co-infected patients: A frustrating reality in some scenarios.

p.465, EACS2023: 877 | Impact of COVID-19 pandemic on Cascade of Care of Hepatitis C (HCV) among persons with HIV/HCV co-infection in Greece: A single-center cohort.

p.465, EACS2023: 887 | Hepatitis B and C co-infection in HIV infected patients attending the National Centre for Infectious Disease in Armenia.

p.473–4, EACS2023: 84 | Association between electronic and conventional cigarette use and perceived stress levels among PLHIV Filipinos in a community-led HIV clinic: A cross-sectional study.

p.474, EACS2023: 172 | Birth stories of women living with HIV.

p.478, EACS2023: 441 | Applying the HIV community advisory model to research on COVID-19 vaccine Considerations from the first year of community engagement in the RBDCOV project.

p.487, EACS2023: 69 | Lessons learned from integrating oral PrEP and family planning services in public health facilities in Uganda.

p.500, EACS2023: 491 | Public perception of the FDA approval of a long-acting injectable for HIV prevention: Natural language processing study.

p.510, EACS2023: 921 | Sexual practices, condom use and chemsex in a population of MSM PrEP users in Argentina.

p.512–13, EACS2023: 4 | The Nigerian natNonal PMTCT project: Challenges and prospects.

p.513, EACS2023: 40 | Factors affecting utilization of family planning services by HIV positive women attending HIV clinics at TASO Gulu, TASO Mulago, TASO Tororo and TASO Masaka.

p.515, EACS2023: 18 | FADE OUT HIV: Results of an educational intervention allying Black community, barbers, their clients and community clinicians.

p.523, EACS2023: 344 | Identifying recent and long-term HIV infection through a combination of analyses in Bulgaria.

p.526, EACS2023: 528 | Evaluation of people living with HIV followed up in our hospital.

p.533–4, EACS2023: 739 | Prevalence of human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), and syphilis infection among Egyptian drug users: Findings from an integrated screening initiative.

p.534, EACS2023: 757 | New HIV diagnosis during the COVID-19 pandemic: Retrospective study in a Portuguese hospital.

p.538, EACS2023: 802 | Acute HIV infection in a tertiary hospital in Portugal.

p.544–5, EACS2023: 239 | Evaluation of the knowledge level of 9-valent HPV vaccine in medical faculty students.

p.564, EACS2023: 56 | Controlling the spread of HIV among long haulage workers in Nigeria.

p.566, EACS2023: 223 | Scaling up COVID 19 response among adolescents and young people in Limbe health district.

p.576, EACS2023: 263 | Left main coronary interventions in people living with HIV—A real world experience.

p.577, EACS2023: 572 | Palliative care model for muscular pain alleviation in PLHIV undergoing ARV therapy.

p.583–4, EACS2023: 996 | Sexual behavioural factors that influence the utilization of sexual reproductive services among young people living with HIV in Nairobi County.

p.584, EACS2023: 999 | Telemedicine vs. face-to-face visits: Multidimensional assessment and patient reported outcomes in people living with HIV.

p.585, EACS2023: 52 | The Hidden Crisis ‘The causes and consequences of sexualised drug use in Pakistan among transgender community and key population’.

p.586, EACS2023: 166 | Focus on cannabidiol (CBD) to reduce alcohol consumption: A qualitative approach.

p.595, EACS2023: 864 | Vitamin D and depressive disorder in a HIV positive patients: Dual therapy (DTG based) versus standard triple therapy.

p.602, EACS2023: 12 | Community driven approach to address HIV/AIDS awareness in Quetta, Pakistan.

p.602, EACS2023: 568 | Alternative medicine system (CAM) and muscle pain control in HIV cases: Newer approaches in resource restricted nations.

p.603, EACS2023: 58 | Hurdles in HIV-vaccines development in Asian population: Advocacy efforts needs encouragement from international community.

p.603, EACS2023: 60 | HIV/AIDS prevention initiatives by rural/tribal community based organizations in rural/tribal Asia.

p.604–5, EACS2023: 552 | HIV-vaccines development obstacles in Asian countries.

p.605, EACS2023: 559 | Experiences with use of alternative therapy to improve treatment of PLHIV in resource limited countries.

p.606, EACS2023: 15 | HIV-Tuberculosis co-infection, about 47 patients.

p.612, EACS2023: 457 | ADA in cerebrospinal fluid in patients with HIV/AIDS infection and meningeal tuberculosis.

p.625, EACS2023: 93 | Socio-cultural factors influence the uptake of the prevention of mother-to-child transmission (PMTCT) program: A critical ethnographic study.

p.627, EACS2023: 280 | Lesotho progress towards HIV free generation through decentralized point of care diagnostics for HIV exposed infants.

p.628, EACS2023: 632 | A systematic review of PMTCT scale up: Reaching the underserved pregnant women with PMTCT services through expansion to communities in Kwara state, Northcentral Nigeria.

p.649, EACS2023: 798 | Nonalcoholic fatty liver disease in people living with HIV without hepatitis B virus and C virus co-infection and without factors associated with liver steatosis diagnosed by controlled attenuation parameter.

p.654, EACS2023: 861 | ABCB1 expression in human liver tissue of HIV/HBV patients.

p.656, EACS2023: 198 | Use of technology for effective outreach among MSM population in virtual space.

p.657, EACS2023: 487 | Barriers and facilitators to receiving mpox vaccines among men who have sex with men in Hong Kong: A qualitative study.

p.668, EACS2023: 954 | Infants and young child feeding in emergencies—Polish commentary and assessment of the current situation.

p.674, EACS2023: 852 | Recognizing the intersection of HIV, biology and comorbidities in women living with HIV: Impact of online independent medical education on physician knowledge and confidence.

p.674, EACS2023: 867 | Increasing understanding and optimizing management of weight gain in women living with HIV: Effect of online education on physician knowledge and confidence.

p.688–89, EACS2023: 1079 | To study occurrence of hearing loss in children living with HIV.

p.690, EACS2023: 1082 | To study the musculoskeletal manifestations in children living with HIV.

p.693–4, EACS2023: 1155 | Triple testing for HIV, Hepatitis B and Hepatitis C: A systematic review evaluating the prevalence of HIV, Hepatitis B and Hepatitis C to provide support for the WHO's recommendation of triple testing.

p.694, EACS2023: 1057 | Global, close and free monitoring of keys populations in a public hospital: Experience of the Logbaba District Hospital (Douala/Cameroon).

p.697–8, EACS2023: 1156 | A systematic review and metaanalysis comparing the effectiveness of dual therapy to either corticosteroid monotherapy or pentoxifylline monotherapy in severe alcoholic hepatitis.

p.699, EACS2023: 1054 | Stigmatization of people living with HIV/AIDS: A case study of how young positives overcome psychological trauma in Nigeria, West Africa.

p.702, EACS2023: 1103 | Low rate of successful tuberculosis treatment outcomes among HIV/TB coinfected patients in a referral hospital in Cameroon.

p.705, EACS2023: 1141 | Use of modern social media to improve tracking and addressing stock-outs by community-based organizations.

p.707, EACS2023: 1070 | The barriers and facilitators within HIV and STI testing interventions for Black African and Black Caribbean migrants in the United Kingdom: A systematic review and narrative synthesis.

p.709, EACS2023: 19 | Therapeutic management of a paediatric patient with resistance to the integrase group.

p.709–10, EACS2023: 21 | Toxoplasmic encephalitis and invasive pulmonary aspergillosis in patient with acquired immunodeficiency syndrome.

p.710, EACS2023: 39 | Three-class drug resistance in a HIV treatment-naive individual: Reported for the first time in the GCC countries.

p.711–12, EACS2023: 103 | Diffuse gingival hypertrophied Kaposi sarcoma as an initial presentation of HIV clinical case.

p.713, EACS2023: 112 | HIV associated dementia: A case report of a late-presenter patient.

p.714, EACS2023: 117 | Difficult journey of a young boy with missed HIV test.

p.719–20, EACS2023: 182 | Respiratory failure complicated by third degree atrioventricular block and rightsided pneumothorax in a patient living with HIV and successfully treated with antiretroviral therapy.

p.723–4, EACS2023: 228 | Проведення інформаційної роботи серед медичних працівників у сфері репродуктивного здоров'я жінок та гінекології.

p.724, EACS2023: 286 | Comorbidity of myasthenia gravis and Grave's disease as late-onset immune reconstitution inflammatory syndrome in HIV infection: A case report and literature review.

p.727, EACS2023: 321 | Fostering continuity of care for adolescents living with HIV through targeted youth camps in Kisumu, Kenya.

p.727, EACS2023: 327 | Enhancing care and viral load suppression among adolescents living with HIV/AIDS through a youth-friendly center: A case study from Kisumu County Referral Hospital.

p.730, EACS2023: 376 | Left main bifurcation PCI in an adult with double positive (retroviral-positive and COVID positive).

p. 732–3, EACS2023: 427 | Kaposi sarcoma in an HIV positive patient, presentation of a case from the metropolitan area of Medellín, Colombia.

p.733–4, EACS2023: 438 | Crossing the bridge: A challenging case presentation illustrating the use of dual antiretroviral therapy in a pregnant woman living with HIV.

p.734, EACS2023: 459 | Histoplasmosis disseminated to the skin in a patient with HIV/AIDS.

p.736, EACS2023: 715 | Difficulties in management of the white lesions of the tongue: A case report.

p.737, EACS2023: 752 | The risk of HIV transmission from mother to child, about a series of 53 children.

p.738–9, EACS2023: 939 | Pneumocystis jirovecii pneumonia with CMV reactivation in a newly diagnosed HIV-infected patient.

p.740, EACS2023: 1010 | First cases of Mpox in Lebanon: A case series.

p.741, EACS2023: 1012 | PrEP in Bosnia and Herzegovina from 2016 until today.

p.743, EACS2023: 1018 | The barriers and facilitators within HIV and STI testing interventions for Black African and Black Caribbean migrants in the United Kingdom: A systematic review and narrative synthesis.

p.744, EACS2023: 1034 | HIV/AIDS and respiratory failure during the COVID-19 pandemic.

p.745, EACS2023: 1036 | Infectious diseases ravaging Africa: A rare presentation of Kaposi sarcoma misdiagnosed as Hansen's disease.

p.747, EACS2023: 1044 | Neurological syndrome with subacute and progressive onset in a late presenting HIV-patient.

p.749, EACS2023: 1049 | Mycobacterial spindle cell pseudotumor – effectiveness of treatment of HIV infection and atypical mycobacteriosis in the context of patient cooperation.

p.750–1, EACS2023: 1065 | Clinical case of chlamydial infection with extragenital localization in HIVpositive men.

p.751, EACS2023: 1067 | Condyloma acuminata in an HIV patient.

p.755, EACS2023: 1087 | Many healthcare providers, one disoriented patient.

p.763, EACS2023: 1111 | TB pancreatitis.

p.767–8, EACS2023: 1116 | HIV-1 infection in a 22-year-old treatment-naïve Ukrainian woman discovered at delivery.

p.768, EACS2023: 1119 | A case of spontaneous clearance of chronic hepatitis C in a HIV late presenter with AIDS condition.

p.771, EACS2023: 1133 | How important is forgiveness? A case report of very low adherence with maintenance of viral suppression.

p.772, EACS2023: 1134 | Management dilemma of advanced HIV disease with hepatotoxicity, acute kidney injury and septic shock requiring ICU care in resource limited Uganda.

p.773, EACS2023: 1135 | Zidovudine: Current use of an old drug – a case of cerebral toxoplasmosis successfully treated in conjunction with a zidovudine-based regimen.

p.773, EACS2023: 1139 | Fast progression from asymptomatic HIV-1 infection to major immune deficiency and Kaposi's sarcoma.

p.775–6, EACS2023: 1157 | Rapid start of an INSTI-based regimen in a patient with uncontrolled diabetes mellitus.

p.778, EACS2023: 1163 | Doravirine/lamivudine/tenofovir disoproxil fumarate as personalized treatment: A case-report of an acute HIV infection.

p.780, EACS2023: 1168 | Miliary TB shadowed with COVID-19 and pneumonia in the mist of severe anaemia in pregnancy newly diagnosed RVI in pregnancy.

p.780, EACS2023: 1170 | HIV and syphilis coinfection with focal neurology, reactive oligoarthritis with elevated serofast reactive syphilis serology.

p.783–4, EACS2023: 1176 | Virological rebound and low drug levels of unknown origin under long-acting Cabotegravir (CAB)/Rilpivirine (RPV).

p.788, EACS2023: 1192 | Navigating the shadows: Refeeding syndrome in late-stage HIV diagnosis – A case report